Table 1.
Author, Year | Cancer Type | Intervention | Participants (Gender, Number, Age) | Intervention | Duration and Timing of Exercise | Observation Period | Measure (Outcome) |
---|---|---|---|---|---|---|---|
Courneya et al,24 2014 | Breast | Ex1 = aerobic exercise Ex2 = resistance training vs Con = usual care |
% female = 100% Ex = 160 <50 years = 90 >50 years = 70 Con = 82 <50 years = 42 >50 years = 40 |
Aerobic exercise: 3 times/week, beginning at 60% of their
VO2max for 1-6 weeks and progressing to 70%
during 7-12 weeks and 80% beyond 12 weeks. Exercise duration
began at 15 minutes for 1-3 weeks and increased by 5 minutes
every 3 weeks until 45 minutes at 18
weeks. Resistance exercise (3 times/week): performing 2 sets of 8-12 repetitions of 9 different exercises at 60% to 70% of their estimated 1 repetition maximum. |
Duration of chemotherapy, beginning 1-2 weeks after starting chemotherapy and ending 3 weeks after completing chemotherapy (at least 18 weeks) | 8 years | DFS, mortality, DDFS, RFI |
Dhillon et al,22 2017 | Lung | Ex = aerobic exercise vs Con = usual care |
% female = 45% Ex = 56 64 (38-80) years Con = 55 64 (34-76) years |
Increasing recreational physical activity (PA) by>3 MET h/week. Sessions lasted 1 hour; 45-minute PA; 15-minute behavior support. PA was predominantly aerobic, and home-based PA was encouraged. | Ambulatory treatment 8 weeks |
6 months | Mortality, PA, accelerometers (min/day) |
Hayes et al,23 2017 | Breast | Ex = aerobic and resistance exercise vs Con = usual care |
% female = 100% Ex = 207 51.7 ± 8.8 years Con = 130 53.9 ± 8.3 years |
Aerobic-based and resistance-based: 180+ minutes, moderate-intensity exercise, to be accumulated on at least 4 days per week. Commencing at 6 weeks postsurgery. | Postsurgery Home exercise 8 months |
96 months | Mortality, DFS |
Jones et al,25 2014 | Mix | Ex = aerobic training vs Con = usual care |
% female = 26% Ex = 47 64 ± 10 years Con = 43 66 ± 11 years Patients with heart failure |
Supervised aerobic training (treadmill or stationary cycle ergometer) sessions per week lasting 20 to 45 minutes per session at 60% to 70% of heart rate reserve. | Ambulatory treatment Home exercise 12 weeks |
12 months | All-cause mortality |
Licker et al,26 2017 | Mix | Ex = high-intensity interval training vs Con = usual care |
% female = 40% Ex = 74 64 ± 13 years Con = 77 64 ± 10 years |
After a 5-minute warm-up period at 50% at peak work rate (peakWR); two 10-minute series of 15-second sprint intervals (at 80% to 100% peakWR) interspersed by 15-second pauses and a 4-minute rest between the 2 series; cooled down with a 5-minute active recovery period at 30% peakWR. | Presurgery Ambulatory treatment (2-3 times/week) |
30 days | Postoperative 30-day mortality |
Rief et al,19 2014 | Mix | Ex = resistance training vs Con = control |
% female = 45% Ex = 30 61.3 ± 10.1 years Con = 30 64.1 ± 10.9 years |
Resistance training: 30 minutes | During hospitalization 2 weeks |
12 weeks | Mortality, pain score |
Rief et al,20 2016 | Mix | Ex = resistance training vs Con = passive physical therapy |
% female = 45% Ex = 30 61.3 ± 10.1 years Con = 30 64.1 ± 10.9 years |
Resistance training: 30 minutes | During hospitalization 2 weeks |
10 months (range = 2-35 months) | Mortality, PFS, bone survival |
Wiskemann et al,21 2015 | Allogeneic hematopoietic stem cell transplant | Ex = endurance exercises and resistance
exercises vs Con = usual care |
% female = 33% Ex = 50 48.2 ± 14.5 years Con = 53 50.0 ± 12.4 years |
A combination of endurance exercises, 3 to 5 times weekly, and resistance exercises twice weekly, with each session lasting 20 to 40 minute. | After allogeneic stem cell transplantation Before and after hospital admission After discharge: 8 weeks |
2 years | NRM, TM |
Abbreviations: Ex, exercise group; Con, control group; VO2max, maximum rate of oxygen consumption; DFS, disease-free survival; DDFS, distant DFS; RFI, recurrence-free interval; MET, metabolic equivalent of task; PFS, progression-free survival; NRM, non-relapse mortality; TM, total mortality.